erythromycin has been researched along with Toxoplasmosis, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg-Candolfi, M; Candolfi, E | 1 |
| Benet, LZ; Berg-Candolfi, M; Candolfi, E | 1 |
| Araujo, FG; Lin, T; Remington, JS | 1 |
| Almadany, R; Chau, F; Derouin, F; Pocidalo, JJ; Rouveix, B | 1 |
| Araujo, FG; Prokocimer, P; Remington, JS | 1 |
| Araujo, FG; Remington, JS; Shepard, RM | 1 |
| Araujo, FG; Remington, JS | 1 |
| Araujo, FG; Guptill, DR; Remington, JS | 1 |
| Chang, HR; Pechère, JC; Rudareanu, FC | 1 |
9 other study(ies) available for erythromycin and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Clindamycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Intestinal Mucosa; Jejunum; Kinetics; Mice; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Reference Values; Time Factors; Toxoplasmosis, Animal | 1996 |
Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression.
Topics: Acetylcysteine; Animals; Antibodies, Monoclonal; Arginine; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Erythromycin; Interferon-gamma; Intestinal Mucosa; Jejunum; Macrophages, Peritoneal; Male; Mice; Mice, Inbred CBA; Microsomes; Microsomes, Liver; Nitrites; Oxidoreductases, N-Demethylating; Toxoplasmosis, Animal | 1996 |
Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Mice; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Topics: Animals; Azithromycin; Brain; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Lung; Mice; Pyrimethamine; Sulfadiazine; Survival Rate; Toxoplasmosis, Animal | 1992 |
Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Evaluation, Preclinical; Erythromycin; Female; Mice; Roxithromycin; Spiramycin; Tissue Distribution; Toxoplasma; Toxoplasmosis, Animal | 1991 |
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.
Topics: Animals; Azithromycin; Dose-Response Relationship, Drug; Drug Synergism; Erythromycin; Female; Interferon-gamma; Mice; Toxoplasmosis, Animal | 1991 |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
Topics: Animals; Azithromycin; Brain Diseases; Erythromycin; Mice; Peritonitis; Toxoplasmosis, Animal | 1988 |
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Topics: Animals; Clarithromycin; Erythromycin; Female; Mice; Mice, Inbred Strains; Toxoplasma; Toxoplasmosis, Animal | 1988 |